http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109762818-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109762818-B |
| titleOfInvention | circ _2157, application thereof in preparation of nasopharyngeal carcinoma diagnostic preparation and diagnostic reagent |
| abstract | The invention belongs to the technical field of tumor molecular biology, and particularly relates to a circular RNA circ _2157, application thereof in preparation of a nasopharyngeal carcinoma diagnosis preparation, and a corresponding preparation. The invention collects a plurality of nasopharyngeal carcinoma tissues and normal inflammatory nasopharyngeal epithelial tissues, and detects the expression condition of circ _2157 by utilizing qRT-PCR technology. The results showed that circ _2157 was significantly highly expressed in 29 nasopharyngeal carcinoma tissues compared to 12 normal inflammatory nasopharyngeal epithelium tissues, and that circ _2157 expression was approximately 5-fold higher in the nasopharyngeal carcinoma group than in the normal inflammatory nasopharyngeal epithelium, and the difference between the two groups of data was statistically significant (P ═ 0.0279). Therefore, the circRNA circ _2157 is highly expressed in nasopharyngeal carcinoma tissues, and the circRNA circ _2157 possibly has important biological functions for the occurrence and development of nasopharyngeal carcinoma and can be used as a nasopharyngeal carcinoma diagnosis molecular marker. |
| priorityDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.